COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients

BACKGROUND: The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised patients has not been systematically evaluated. METHODS: We reviewed current literature reporting on COVID-19 in cancer (CA), he...

Descripción completa

Detalles Bibliográficos
Autores principales: Belsky, Jennifer A., Tullius, Brian P., Lamb, Margaret G., Sayegh, Rouba, Stanek, Joseph R., Auletta, Jeffery J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of The British Infection Association. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859698/
https://www.ncbi.nlm.nih.gov/pubmed/33549624
http://dx.doi.org/10.1016/j.jinf.2021.01.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859698/
https://www.ncbi.nlm.nih.gov/pubmed/33549624
http://dx.doi.org/10.1016/j.jinf.2021.01.022

Ejemplares similares